戻る Agendas
NEW DEVELOPMENTS, EBOLA VACCINES
Session Chair(s)
Richard Pilsudski
Global Regulatory Affairs
Sanofi Pasteur SA, France
Jan Willem van der Laan, PHD
Senior Assessor Pharmacology and Toxicology
Retired From Medicines Evaluation Board, Netherlands
rVSV-ZEBOV-GP Vaccine: Development Update and Regulatory Considerations
Speaker(s)
Accelerated Development of a Heterologous Prime Boost Approach Combining Ad26.ZEBOV and MVA-BN-FILO
Benoit Callendret, DVM, PHD
Janssen (Crucell), Netherlands
Compound Development Team Leader
rVSV-ZEBOV-GP Vaccine: Development Update and Regulatory Considerations
Geert Preuveneers, MBA, MSC
Merck & Co., Inc, Belgium
ED, EU TAL
Regulatory Activities Related to Ebola Vaccines – EMA perspective
Marco Cavaleri, PHD
European Medicines Agency, Netherlands
Head of Health Threats and Vaccines Strategy